NCS events provide valuable workshops, keynotes, conferences, and programs designed to help scientists advance their careers. These events also foster global connections, enabling scientists to build and strengthen their professional networks.
Events
Online and in-person events created
to help scientists advance their career.

Cell Therapies for Cancer
11 April, 2024
Watch1/3
According to the World Health Organization, cancer is the second leading cause of death worldwide. This webinar presents the complex world of cancer diseases and the recent advances in cell therapies to fight against them. With the participation of Fábio Rosa (Ph.D., Co-founder and Head of Research at Asgard Therapeutics), Paula Videira (Ph.D., Associate Professor at NOVA University of Lisbon and Co-founder of CellmAbs), and Mariana Silva (Ph.D., Senior Scientist at Vor Biopharma) in a discussion to learn more about the present and future of cell therapies for cancer.

Frontiers in Aging: Principles of Longevity
02 May, 2024
Watch2/3
How can we live longer and healthier? This is probably one of the most asked questions in the XXI century. This webinar focuses on aging and its effects on longevity in several aspects of human biology. A round table with Claudia Cavadas (PharmD, Ph.D., Researcher and Professor at the University of Coimbra), Joris Deelen (Ph.D., Research Group Leader at Max Planck Institute for Biology of Ageing) and José Pedro Castro (Ph.D., Assistant Professor and Researcher at i3S – Instituto de Investigação e Inovação em Saúde) to understand the most recent discoveries in the field of longevity and about the frontiers in aging. Discussion to learn more about the present and future of cell therapies for cancer.

AI in Drug Discovery: Present and Future
16 May, 2024
Watch3/3
Developing a new drug is costly and time-consuming, leading to a low number of innovative drugs used, with consequences for patients with a wide range of diseases. This webinar explores using Artificial Intelligence (AI) as the motive force for innovation and improvement in drug discovery. Rani Powers (Ph.D., Founder and CEO at Pluto), Kristina Ulicna (Ph.D., Research Scientist at Valence Labs), and Ricardo Nascimento dos Santos (Ph.D., Principal Data Scientist at Sanofi) discuss AI as the leader of a new revolution in drug discovery and development processes.